3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
4
Burkitt Lymphoma
4
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Follicular
2
Leukemia, Biphenotypic, Acute
2
Down Syndrome
2
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hodgkin Disease
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
pembrolizumab
71
Carboplatin
71
Pemetrexed
60
Cisplatin
46
Nivolumab
30
Specimen Handling
29
Paclitaxel
29
durvalumab
26
Magnetic Resonance Spectroscopy
24
Docetaxel
23
osimertinib
22
Gemcitabine
18
amivantamab
14
Cetuximab
14
130-nm albumin-bound paclitaxel
13
atezolizumab
12
Radiosurgery
12
lazertinib
11
Ipilimumab
10
Ramucirumab
9
Radiotherapy
9
Bevacizumab
9
cemiplimab
8
alectinib
8
Taxes
8
Drug Therapy
8
Observation
6
Radiation
5
Leucovorin
5
Immunoglobulin G
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Prednisolone
×
30 days
×
Clear all
No trials found.